Aug 31, 2022, 01:00 AM by User Not Found

Bio-IT World | A new gene-editing technology center opens in Pittsburgh; phage-derived gene delivery vehicles create central nervous system genetic medicines; a new CAR-T cell therapy aims to help people with HIV; and more.

Aug 30, 2022, 11:03 AM by

Next-generation sequencing (NGS) is quickly becoming the platform of choice for tumor molecular profiling due to its ability to simultaneously report on multiple biomarkers. However, lengthy turnaround times can limit the clinical utility of these results. To meet the need for rapid genomic insights, Thermo Fisher Scientific today launched the CE-IVD (IVDD) Oncomine Dx Express Test and Oncomine Reporter Dx for use in clinical labs.

Aug 30, 2022, 11:03 AM by

Industry-leading Risk-Based Quality Management event focuses on the maturity of RBQM, its increasing value, and the vision for the future CluePoints Hosts RBQM Live 2022 as the Premier Event Sponsor

Aug 30, 2022, 11:02 AM by

ZeOmega®, the leading population health management organization, today announced that it is featured in the KLAS Research CMS Payer Interoperability 2022 Vendor Guide. The report lists ZeOmega as one of the top performing companies whose solutions help payers comply with regulations for secure data exchange.

Aug 30, 2022, 10:59 AM by

Rho, a full-service contract research organization (CRO) with a proven track record of drug development success, today announced findings from a clinical trial it supported as the Statistical and Clinical Coordinating Center for the Inner-City Asthma Consortium (ICAC) to assess the efficacy of a monoclonal antibody for reducing asthma attacks in disadvantaged urban youth.

Aug 30, 2022, 10:58 AM by

MMS Holdings, a data-focused contract research organization, announced the appointment of Kelly J. Hill to Chief Strategy Officer. This announcement comes as the company is accelerating in growth after its partnership with a private equity firm.

Aug 30, 2022, 08:00 AM by User Not Found

Bio-IT World | Lawmakers and animal welfare groups are calling for the FDA to abolish animal testing requirements for products under its jurisdiction.

Aug 30, 2022, 01:00 AM by User Not Found

Bio-IT World | AI-enabled drug discovery and sustainable development, a novel antitumor glioma platform, virtual reality operating theaters, and more.

Aug 26, 2022, 10:06 AM by

Aug 26, 2022, 10:05 AM by

Aug 26, 2022, 10:05 AM by

Aug 26, 2022, 10:04 AM by

Aug 26, 2022, 10:02 AM by

Aug 26, 2022, 10:01 AM by

Aug 25, 2022, 10:16 AM by

Aug 25, 2022, 10:15 AM by

Aug 25, 2022, 10:15 AM by

Aug 25, 2022, 10:15 AM by

Aug 25, 2022, 10:14 AM by

A leader in continuous remote patient monitoring and data analytics, physIQ today announced a strategic collaboration with InCarda Therapeutics, Inc., a privately-held, clinical-stage biopharmaceutical company developing first-of-their-kind inhaled therapies for cardiovascular diseases. Syneos Health® (Nasdaq:SYNH), the only fully integrated biopharmaceutical solutions organization, recommended physIQ’s innovative monitoring solution to help advance InCarda’s clinical study of InRhythm™ (orally inhaled flecainide) in patients with atrial fibrillation (AF) – one of the most common heart arrhythmias that affects one in four adults over the age of 40.1

Aug 25, 2022, 10:13 AM by